Atea Pharmaceuticals, Inc. (AVIR) Operating cash flow 2018–2025
Atea Pharmaceuticals, Inc. (AVIR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$132.0MFY2025 · since FY2018: -$7.9M → -$132.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$132.0M | +2.6% |
| FY2024 | -$135.5M | -58.7% |
| FY2023 | -$85.4M | +29.4% |
| FY2022 | -$121.0M | -39.1% |
| FY2021 | -$87.0M | -129.3% |
| FY2020 | $296.7M | +2413.0% |
| FY2019 | -$12.8M | -62.2% |
| FY2018 | -$7.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice